These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2789952)

  • 1. Tumour marker antigens during menses and pregnancy.
    Touitou Y; Darbois Y; Bogdan A; Auzéby A; Keusseoglou S
    Br J Cancer; 1989 Sep; 60(3):419-20. PubMed ID: 2789952
    [No Abstract]   [Full Text] [Related]  

  • 2. Transformation of histological tumor type of the cervix expressed in different tumor markers in the serum.
    Aalders JG; de Bruijn HW; Oosterhuis JW; Duk JM
    Gynecol Oncol; 1990 Jan; 36(1):110-2. PubMed ID: 2295441
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumour marker immunoreactivity in adenocarcinoma.
    Ellis IO; Hitchcock A
    J Clin Pathol; 1988 Oct; 41(10):1064-7. PubMed ID: 3192728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of radioimmunoanalysis of tumor markers in the diagnosis of carcinoma of the breast, ovary and intestines].
    Kausitz J
    Bratisl Lek Listy; 1988 Aug; 89(8):563-76. PubMed ID: 3179762
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical significance of the number of positive tumor markers in assisting the diagnosis of lung cancer with multiple tumor marker assay.
    Mizushima Y; Hirata H; Izumi S; Hoshino K; Konishi K; Morikage T; Maruyama M; Yamashita N; Yano S
    Oncology; 1990; 47(1):43-8. PubMed ID: 2300384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mucoid carcinoma antigen--a new tumor marker].
    Bieglmayer C; Szepesi T; Neunteufel W
    Gynakol Rundsch; 1988; 28 Suppl 2():203-5. PubMed ID: 3234919
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical and immunologic diagnosis of cancer. Colorectal cancer.
    von Kleist S
    Tumour Biol; 1987; 8(2-3):78-83. PubMed ID: 3329404
    [No Abstract]   [Full Text] [Related]  

  • 8. [A clinical study on CA 15-3, CEA, SCC-Ag in patients with squamous cell carcinoma of the lung].
    Moriya H; Suzuki S; Aizumi J; Kimura K; Urabe S; Higuci Y; Hoshi K
    Rinsho Hoshasen; 1989 Jan; 34(1):63-6. PubMed ID: 2724610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
    Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW
    Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination assay of tumor markers in predicting the effectiveness of chemotherapy in non-small lung cancer].
    Satoh H; Yano H; Suyama T; Hasegawa S
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):127-9. PubMed ID: 1346084
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical significance of present tumor markers].
    Ohkura H
    Gan To Kagaku Ryoho; 1993 May; 20(7):843-9. PubMed ID: 7683865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fundamental and clinical evaluation of IRMA for serum SPan-1 antigen].
    Fukuda Y; Murakami M; Fukuchi M
    Kaku Igaku; 1990 Apr; 27(4):405-13. PubMed ID: 2165543
    [No Abstract]   [Full Text] [Related]  

  • 13. [Improving the diagnostic efficacy of carcinoembryonic antigen (CEA) in gastric cancer by the simultaneous administration of Ca 72.4].
    Sagredo E; Soriano A; Vivanco FJ; Ruibal A
    Rev Clin Esp; 1989 Apr; 184(6):336-7. PubMed ID: 2756226
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumour associated antigens in diagnosis of serous effusions.
    Mezger J; Permanetter W; Gerbes AL; Wilmanns W; Lamerz R
    J Clin Pathol; 1988 Jun; 41(6):633-43. PubMed ID: 2454957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of tumor markers in the management of patients with gynecologic carcinomas.
    Berchuck A; Boente MP; Bast RC
    Clin Obstet Gynecol; 1992 Mar; 35(1):45-54. PubMed ID: 1544249
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical and immunologic diagnosis of cancer. Pancreatic and gastric cancer.
    Burtin P
    Tumour Biol; 1987; 8(2-3):84-5. PubMed ID: 2452469
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of five tumor marker assay in patients with lung cancer.
    Mizushima Y; Tsuji H; Izumi S; Hirata H; Kin Y; Kawasaki A; Matsui S; Yano S
    Anticancer Res; 1991; 11(1):91-5. PubMed ID: 2018388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hemodialysis on the concentration of the seven tumor markers carcinoembryonic antigen, alpha-fetoprotein, squamous cell carcinoma-related antigen, neuron-specific enolase, CA 125, CA 19-9 and CA 15-3 in uremic patients.
    Odagiri E; Jibiki K; Takeda M; Sugimura H; Iwachika C; Abe Y; Kihara K; Kihara Y; Itou M; Nomura T
    Am J Nephrol; 1991; 11(5):363-8. PubMed ID: 1725572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical determination of antigen 19-9 (CA 19-9) in transitional carcinoma of the bladder].
    Casetta G; Cavallini A; Piana P; Squintone L; Vottero M; Tizzani A
    Minerva Urol Nefrol; 1992; 44(3):169-72. PubMed ID: 1492266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and biochemical markers in colorectal cancer.
    McDermott U; Longley DB; Johnston PG
    Ann Oncol; 2002; 13 Suppl 4():235-45. PubMed ID: 12401696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.